Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 370

Helicobacter H. pylori

Illustrative A nurse in a hospital, in Israel, on September 3, 2017. (Hadas Parush/Flash90)
March 10, 2020, 1:36 pm
Israel’s Redhill Biopharma launches US sales of anti-bacterial drug
Firm’s Talicia pill combats H. pylori bacteria, a major carcinogen which affects some 2 million US adults
By Luke Tress
RedHill's RHB-105 or Talicia drug for H. pylori. (Courtesy)
November 4, 2019, 3:12 pm
RedHill gets FDA nod for drug to eradicate gut infection
Israeli firm plans to start selling the pill in the US in first quarter 2020, targeting more than 2 million patients treated for H. pylori infection annually; shares surge
By Shoshanna Solomon
RedHill's RHB-105 or Talicia drug for H. pylori. (Courtesy)
May 7, 2019, 2:53 pm
RedHill seeks FDA nod for drug to eradicate gut infection
If the Talicia drug to combat H. pylori bacterial infection gets approved, commercial launch is planned for the fourth quarter of 2019, Israeli firm says
By Shoshanna Solomon
RedHill's RHB-105 or Talicia drug for H. pylori. (Courtesy)
December 3, 2018, 5:58 pm
Israel’s RedHill says drug shown effective in eradicating gut infection
Biotech firm’s Talicia drug was found in a late-stage study to vanquish H. pylori in 84% of patients; the bacteria can cause ulcers and gastric cancer
By Shoshanna Solomon
Illustrative. (Bet_Noire; iStock by Getty Images)
October 24, 2018, 11:59 am
RedHill gets added backwind for drug to treat Crohn’s disease
Israeli biopharmaceutical firm is also awaiting results of critical study on its drug to combat H. pylory, the bacteria that can cause peptic ulcer and gastric cancer
By Shoshanna Solomon
RedHill CEO Dror Ben Asher (Screenshot)
June 15, 2015, 6:59 pm
Israeli ulcer-preventing drug shows top results in study
H. pylori, a principal cause of ulcers and even gastric cancer, has met its match in RedHill Biopharma’s RHB-105 treatment
By David Shamah
Load More
Sign in or Register
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.